191739-40-9 Usage
General Description
4-N-CBZ-2-HYDROXYMETHYL-PIPERAZINE is a chemical compound with the molecular formula C13H18N2O3. It is a derivative of piperazine and is commonly used in the pharmaceutical industry as a building block for the synthesis of various drugs. 4-N-CBZ-2-HYDROXYMETHYL-PIPERAZINE is known for its role as a linker in the design of novel drug candidates with potential therapeutic applications. It is also used in the development of prodrugs, which are inactive compounds that are metabolized in the body to produce active drugs. Additionally, 4-N-CBZ-2-HYDROXYMETHYL-PIPERAZINE has been studied for its potential as an ingredient in the formulation of controlled-release drug delivery systems. Overall, this compound has significant importance in drug development and has a variety of applications in the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 191739-40-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,7,3 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 191739-40:
(8*1)+(7*9)+(6*1)+(5*7)+(4*3)+(3*9)+(2*4)+(1*0)=159
159 % 10 = 9
So 191739-40-9 is a valid CAS Registry Number.
InChI:InChI=1/C13H18N2O3/c16-9-12-8-15(7-6-14-12)13(17)18-10-11-4-2-1-3-5-11/h1-5,12,14,16H,6-10H2
191739-40-9Relevant articles and documents
IMIDAZOPYRAZINE SYK INHIBITORS
-
Paragraph 0440, (2014/01/08)
Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating patients suf-fering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of an imidazopyrazine compound effective to reduce signs or symptoms of the disease or dis-order are provided.
Oxazolidinone antibacterial agent with tricyclic substituents
-
, (2008/06/13)
This invention provides novel oxazolidinone derivatives represented by chemical Formula (I), or pharmaceutically acceptable salts thereof: STR1 wherein X is NR1, CR2 R3, O, S, SO, or SO2 ; and Z is NR4/sub